Gene ARRDC1 for diagnosing dengue fever and dengue hemorrhagic fever and application thereof

A technology of ARRDC1 and dengue hemorrhagic fever, which is applied in the field of diagnosis of dengue fever and the ARRDC1 gene of dengue hemorrhagic fever, can solve the problems of difficult diagnosis and complicated clinical manifestations of dengue virus infection, and achieve accurate results, good detection sensitivity and specificity Effect

Inactive Publication Date: 2018-09-28
QINGDAO MEDINTELL BIOMEDICAL CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] The clinical manifestations of dengue virus infection are very complex, and most of the symptoms are indistinguishable from diseases such as malaria, typhoid fever, and chikunguny

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gene ARRDC1 for diagnosing dengue fever and dengue hemorrhagic fever and application thereof
  • Gene ARRDC1 for diagnosing dengue fever and dengue hemorrhagic fever and application thereof
  • Gene ARRDC1 for diagnosing dengue fever and dengue hemorrhagic fever and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Example 1 Screening of genes differentially expressed in patients with dengue fever and / or dengue hemorrhagic fever and normal people

[0046] 1. Research object:

[0047] Disease group: Collect 5 patients with dengue fever, 5 patients with dengue hemorrhagic fever, all patients according to "WHO / TDR.Dengue-Guidelines for diagnosis, Treatment, prevention and control.2009; http: / / www.who.int / tdr / publications / training-guideline-publications / dengue-diagnosis-treatment / en / index.html.Date of Access: 12 / 05 / 2015.2009" for diagnosis.

[0048] Normal group: 4 healthy volunteers were selected.

[0049] There was no significant difference in age and gender between the two groups (P>0.10), which were comparable.

[0050] All research subjects were informed about this study and signed the informed consent.

[0051] 2. Extraction of total RNA in blood

[0052] (1) Fresh whole blood, erythrocyte lysate (1:1), mix by inverting several times, let stand for 5 minutes. 10000g, 4°C, ...

Embodiment 2

[0069]Example 2 Reverse transcription PCR experiment verifies the genes differentially expressed in patients with dengue fever and / or dengue hemorrhagic fever and normal people

[0070] The differentially expressed gene-ARRDC1 gene screened out in Example 1 was selected for large sample verification.

[0071] 1. Research object:

[0072] Disease group: Collect 30 patients with dengue fever, 25 patients with dengue hemorrhagic fever, all patients according to "WHO / TDR.Dengue-Guidelines for diagnosis, Treatment, prevention and control.2009; http: / / www.who.int / tdr / publications / training-guideline-publications / dengue-diagnosis-treatment / en / index.html.Date of Access: 12 / 05 / 2015.2009" for diagnosis.

[0073] Normal group: select 30 cases of healthy volunteers.

[0074] There was no significant difference in age and gender between the two groups (P>0.10), which were comparable.

[0075] All research subjects were informed about this study and signed the informed consent.

[0076]...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses application of a gene ARRDC1 in diagnosis of dengue fever and dengue hemorrhagic fever. The content of the gene ARRDC1 in the blood with dengue fever and dengue hemorrhagic fever is obviously different from the content of the gene ARRDC1 in the blood of a normal person; a patient with dengue fever and dengue hemorrhagic fever and the normal person can be distinguished according to the difference. The invention also discloses a product for diagnosing the dengue fever and dengue hemorrhagic fever. The diagnosing product can be used for diagnosing the dengue fever and dengue hemorrhagic fever by detecting the gene ARRDC1 in the blood.

Description

technical field [0001] The invention belongs to the field of epidemiological diagnosis and prevention, and relates to an ARRDC1 gene for diagnosing dengue fever and dengue hemorrhagic fever and its application. Background technique [0002] Since the Antonine plague (Shrap R, Lotka A J.A Problem in AgeDistribution[J].Philosophical Magazine, 1911,21:35-438) in the 2nd century AD, infectious diseases have been endangering human health and brought huge impacts on social stability. Impact. In recent years, the incidence of dengue infectious disease has increased rapidly and has become a world public health problem, and it is recorded as a disease in Appendix II of the newly revised International Health Regulations (2005). Dengue fever is an acute infectious disease caused by dengue virus and transmitted by Aedes mosquitoes. At first, people named it joint fever and fracture fever according to its symptoms (Monath, T.P. Dengue: The risk to developed and developing countries: Pr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12Q1/70C12Q1/686C12N15/11
CPCC12Q1/686C12Q1/701C12Q2521/107Y02A50/30
Inventor 贾宏毅向常娟
Owner QINGDAO MEDINTELL BIOMEDICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap